BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9251027)

  • 1. Generation of phosphorylated cyclin-dependent kinase 2 and functional characterization of threonine-160-specific phosphatase KAP.
    Poon RY
    Methods Enzymol; 1997; 283():283-92. PubMed ID: 9251027
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of mammalian cyclin-dependent kinase 2.
    Sheaff RJ
    Methods Enzymol; 1997; 283():173-93. PubMed ID: 9251019
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
    Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
    J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases.
    Hannon GJ; Casso D; Beach D
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1731-5. PubMed ID: 8127873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin.
    Poon RY; Hunter T
    Science; 1995 Oct; 270(5233):90-3. PubMed ID: 7569954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6.
    Phelps DE; Xiong Y
    Methods Enzymol; 1997; 283():194-205. PubMed ID: 9251020
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and reconstitution of cyclin-dependent kinase 2 in four states of activity.
    Russo AA
    Methods Enzymol; 1997; 283():3-12. PubMed ID: 9251007
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of protein kinase regulation by protein phosphatases.
    Barford D
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):385-91. PubMed ID: 11497994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and crystallization of the CDK-associated protein phosphatase KAP expressed in Escherichia coli.
    Hanlon N; Barford D
    Protein Sci; 1998 Feb; 7(2):508-11. PubMed ID: 9521129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Picture story. Reining in CDK.
    Feng H
    Nat Struct Biol; 2001 May; 8(5):391. PubMed ID: 11323710
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
    Song H; Hanlon N; Brown NR; Noble ME; Johnson LN; Barford D
    Mol Cell; 2001 Mar; 7(3):615-26. PubMed ID: 11463386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cdk2 binding domain of p27Kip correlates with the inhibition of the kinase activity of cdk2/cyclin complexes.
    Kwon TK; Buchholz MA; Nordin AA
    Biochem Biophys Res Commun; 1996 Mar; 220(3):703-9. PubMed ID: 8607829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant.
    Yeh CT; Lu SC; Chao CH; Chao ML
    Biochem Biophys Res Commun; 2003 May; 305(2):311-4. PubMed ID: 12745075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2.
    Chinami M; Yano Y; Yang X; Salahuddin S; Moriyama K; Shiroishi M; Turner H; Shirakawa T; Adra CN
    J Biol Chem; 2005 Apr; 280(17):17235-42. PubMed ID: 15671017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structuring cell-cycle biology.
    Levine K; Cross FR
    Structure; 1995 Nov; 3(11):1131-4. PubMed ID: 8591023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under arrest at atomic resolution.
    Morgan DO
    Nature; 1996 Jul; 382(6589):295-6. PubMed ID: 8684452
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
    Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
    Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.